Apellis Pharmaceuticals (1JK.F) Q1 2025 Earnings

28FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.5
-0.43
-0.35
-0.27

Details

Expected EPS
-0.3560145468
Actual EPS
-0.27944399999999997
Surprise EPS
0.08
Surprise Percent
+21.51%

Description

Apellis Pharmaceuticals (1JK.F) has reported earnings of -0.27944399999999997 per share for Q1 2025.

0 Comments

Share your thoughts